IGF-binding protein-1 levels are related to insulin-mediated glucose disposal and are a potential serum marker of insulin resistance

Betty A. Maddux, Adelene Chan, Lawrence J. Mandarino, Ira D. Goldfine

    Research output: Contribution to journalArticle

    48 Citations (Scopus)

    Abstract

    OBJECTIVE- IGF-binding protein (IGFBP)-1 is negatively regulated by insulin. We determined whether the measurement of IGFBP-1 in serum is a useful marker of insulin resistance. RESEARCH DESIGN AND METHODS - Twenty-three subjects underwent a euglycemic insulin clamp. Glucose disposal rates (M) were then correlated with measurements of IGFBP-1, fasting insulin levels, homeostasis model assessment (HOMA), and BMI. RESULTS - IGFBP-1 levels more strongly correlated with M (R = 0.73) than the other parameters such as BMI or HOMA. The level of this protein decreased in individuals who became more insulin sensitive by exercise training. CONCLUSIONS - These studies show a strong correlation between insulin sensitivity and the serum levels of IGFBP-1. These studies suggest, therefore, that measurement of this protein may be valuable in identifying those individuals with insulin resistance and those individuals who respond to interventional strategies.

    Original languageEnglish (US)
    Pages (from-to)1535-1537
    Number of pages3
    JournalDiabetes Care
    Volume29
    Issue number7
    DOIs
    StatePublished - 2006

    Fingerprint

    Insulin-Like Growth Factor Binding Protein 1
    Insulin Resistance
    Biomarkers
    Insulin
    Glucose
    Homeostasis
    Glucose Clamp Technique
    Serum
    Fasting
    Proteins
    Research Design
    Exercise

    ASJC Scopus subject areas

    • Internal Medicine
    • Endocrinology, Diabetes and Metabolism

    Cite this

    IGF-binding protein-1 levels are related to insulin-mediated glucose disposal and are a potential serum marker of insulin resistance. / Maddux, Betty A.; Chan, Adelene; Mandarino, Lawrence J.; Goldfine, Ira D.

    In: Diabetes Care, Vol. 29, No. 7, 2006, p. 1535-1537.

    Research output: Contribution to journalArticle

    Maddux, Betty A. ; Chan, Adelene ; Mandarino, Lawrence J. ; Goldfine, Ira D. / IGF-binding protein-1 levels are related to insulin-mediated glucose disposal and are a potential serum marker of insulin resistance. In: Diabetes Care. 2006 ; Vol. 29, No. 7. pp. 1535-1537.
    @article{240d920da32347878f09846ba4c425cb,
    title = "IGF-binding protein-1 levels are related to insulin-mediated glucose disposal and are a potential serum marker of insulin resistance",
    abstract = "OBJECTIVE- IGF-binding protein (IGFBP)-1 is negatively regulated by insulin. We determined whether the measurement of IGFBP-1 in serum is a useful marker of insulin resistance. RESEARCH DESIGN AND METHODS - Twenty-three subjects underwent a euglycemic insulin clamp. Glucose disposal rates (M) were then correlated with measurements of IGFBP-1, fasting insulin levels, homeostasis model assessment (HOMA), and BMI. RESULTS - IGFBP-1 levels more strongly correlated with M (R = 0.73) than the other parameters such as BMI or HOMA. The level of this protein decreased in individuals who became more insulin sensitive by exercise training. CONCLUSIONS - These studies show a strong correlation between insulin sensitivity and the serum levels of IGFBP-1. These studies suggest, therefore, that measurement of this protein may be valuable in identifying those individuals with insulin resistance and those individuals who respond to interventional strategies.",
    author = "Maddux, {Betty A.} and Adelene Chan and Mandarino, {Lawrence J.} and Goldfine, {Ira D.}",
    year = "2006",
    doi = "10.2337/dc05-1367",
    language = "English (US)",
    volume = "29",
    pages = "1535--1537",
    journal = "Diabetes Care",
    issn = "1935-5548",
    publisher = "American Diabetes Association Inc.",
    number = "7",

    }

    TY - JOUR

    T1 - IGF-binding protein-1 levels are related to insulin-mediated glucose disposal and are a potential serum marker of insulin resistance

    AU - Maddux, Betty A.

    AU - Chan, Adelene

    AU - Mandarino, Lawrence J.

    AU - Goldfine, Ira D.

    PY - 2006

    Y1 - 2006

    N2 - OBJECTIVE- IGF-binding protein (IGFBP)-1 is negatively regulated by insulin. We determined whether the measurement of IGFBP-1 in serum is a useful marker of insulin resistance. RESEARCH DESIGN AND METHODS - Twenty-three subjects underwent a euglycemic insulin clamp. Glucose disposal rates (M) were then correlated with measurements of IGFBP-1, fasting insulin levels, homeostasis model assessment (HOMA), and BMI. RESULTS - IGFBP-1 levels more strongly correlated with M (R = 0.73) than the other parameters such as BMI or HOMA. The level of this protein decreased in individuals who became more insulin sensitive by exercise training. CONCLUSIONS - These studies show a strong correlation between insulin sensitivity and the serum levels of IGFBP-1. These studies suggest, therefore, that measurement of this protein may be valuable in identifying those individuals with insulin resistance and those individuals who respond to interventional strategies.

    AB - OBJECTIVE- IGF-binding protein (IGFBP)-1 is negatively regulated by insulin. We determined whether the measurement of IGFBP-1 in serum is a useful marker of insulin resistance. RESEARCH DESIGN AND METHODS - Twenty-three subjects underwent a euglycemic insulin clamp. Glucose disposal rates (M) were then correlated with measurements of IGFBP-1, fasting insulin levels, homeostasis model assessment (HOMA), and BMI. RESULTS - IGFBP-1 levels more strongly correlated with M (R = 0.73) than the other parameters such as BMI or HOMA. The level of this protein decreased in individuals who became more insulin sensitive by exercise training. CONCLUSIONS - These studies show a strong correlation between insulin sensitivity and the serum levels of IGFBP-1. These studies suggest, therefore, that measurement of this protein may be valuable in identifying those individuals with insulin resistance and those individuals who respond to interventional strategies.

    UR - http://www.scopus.com/inward/record.url?scp=33746442534&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=33746442534&partnerID=8YFLogxK

    U2 - 10.2337/dc05-1367

    DO - 10.2337/dc05-1367

    M3 - Article

    C2 - 16801575

    AN - SCOPUS:33746442534

    VL - 29

    SP - 1535

    EP - 1537

    JO - Diabetes Care

    JF - Diabetes Care

    SN - 1935-5548

    IS - 7

    ER -